Alliance Global Partners
VC Fund
New York, United States
Alliance Global Partners is a VC fund in New York focused on Personal Health and Dental. Alliance Global Partners operates through a platform that supports access to domestic exchanges and multiple global markets, enabling clients to participate in a range of securities and asset classes. The firm delivers wealth management services that include internally managed strategies, advisor-managed accounts, and access to external moneymanagers. It also supports fixed income services, retail investment solutions, and insurance-related offerings as part of its advisory structure.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Alliance Global Partners invests in
Stages Alliance Global Partners invests in
Countries Alliance Global Partners invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Craig Klein
|
|||
David Bocchi
|
|||
David Tillman
|
|||
Eric Steingruebner
|
|||
Harry Ioannou
|
Investment Focus
Industry
- Personal Health 2 (50%)
- Dental 1 (25%)
- Cannabis 1 (25%)
- Biopharma 1 (25%)
- Health Care 1 (25%)
Stage
- Post-IPO Equity 2 (50%)
- Seed 1 (25%)
- Post-IPO Debt 1 (25%)
Country
- United States 3 (75%)
- Israel 1 (25%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Craig Klein
Chief Financial Officer
|
Chief Financial Officer | Total investments: 0 | Find email | |
|
David Bocchi
Head Of Investment Banking
|
Head Of Investment Banking | Total investments: 0 | Find email | |
|
David Tillman
Registered Representative
|
Registered Representative | Total investments: 0 | Find email | |
|
Eric Steingruebner
National Sales Manager
|
National Sales Manager | Total investments: 0 | Find email | |
|
Harry Ioannou
Head of Equity Capital Markets
|
Head of Equity Capital Markets | Total investments: 0 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Vivos Therapeutics
|
Vivos Therapeutics Inc. is a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep disordered breathing, including mild to moderate obstructive sleep apnea (OSA). Vivos believes that its Vivos System technology represents the first clinically effective non-surgical,non-invasive, non-pharmaceutical and cost-effective alternative for people with mild-to-moderate OSA. Combining technologies and protocols that can alter the size, shape and position of the tissues of the upper human airway, the Vivos System opens airway space and can significantly reduce symptoms and conditions associated with mild-to-moderate OSA.Vivos Therapeutics was established on January 1, 2013 by Dave Singh and R. Kirk Huntsman in Littleton, Colorado. | $4M / Post-IPO Equity / Oct 31, 2023 | |
Genprex
|
Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprexworks with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. | $4M / Post-IPO Equity / Feb 27, 2023 | |
Mosaic AI
|
Ask-AI aggregates text-heavy company knowledge & customer communications to reveal pinpointed answers and actionable insights. | $9M / Seed / Oct 25, 2022 | |
Harvest Health and Recreation
|
Harvest Health and Recreation is a consistently profitable, vertically integrated cannabis company with one of the largest footprints in the world. Harvest’s industry-leading cultivation, manufacturing, retail facilities, construction, real estate, and technologies are backed by experienced, in-house finance, compliance, operations, real estate,human resources, marketing, and legal teams, who have a proven and trusted track record in the cannabis industry. | $94M / Post-IPO Debt / Dec 24, 2019 |
Co-Investors
GTMfund
2 deals together
Canaccord Genuity Group
1 deal together
Firsthand Technology Value Fund
1 deal together
Gefen Capital
1 deal together
GuideStar Ventures
1 deal together
Interplay
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Alliance Global Partners invest in?
Alliance Global Partners invests primarily in Personal Health, Dental and Cannabis startups, most often at Post-IPO Equity and Seed stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Alliance Global Partners?
Public channels for Alliance Global Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Alliance Global Partners?
The team at Alliance Global Partners includes Craig Klein (Chief Financial Officer), David Bocchi (Head Of Investment Banking) and David Tillman (Registered Representative), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
